Vertex Pharmaceuticals Incorporated (LON:0QZU)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	82,729	82,838	82,315	61,522	41,234	45,014
Market Cap Growth	-16.41%	0.64%	33.80%	49.20%	-8.40%	5.89%
Enterprise Value	74,955	75,287	72,200	54,097	36,741	40,909
Last Close Price	329.36	320.91	319.55	236.58	163.63	171.91
PE Ratio	30.26	-	28.97	22.31	23.84	22.66
PS Ratio	9.49	9.41	10.62	8.30	7.37	9.90
PB Ratio	6.42	6.32	5.96	5.33	5.53	7.08
P/TBV Ratio	7.04	7.15	6.70	6.07	6.42	8.44
P/FCF Ratio	33.32	-	31.42	18.89	23.18	20.53
P/OCF Ratio	29.91	-	29.64	17.95	21.12	18.89
EV/Sales Ratio	8.37	8.55	9.32	7.30	6.57	9.00
EV/EBITDA Ratio	20.02	20.59	20.54	14.40	12.38	17.66
EV/EBIT Ratio	21.63	21.45	21.35	14.89	12.78	18.29
EV/FCF Ratio	30.19	-	27.56	16.61	20.66	18.66
Debt / Equity Ratio	0.11	0.11	0.05	0.07	0.10	0.11
Debt / EBITDA Ratio	0.37	0.37	0.18	0.20	0.24	0.30
Debt / FCF Ratio	0.55	-	0.24	0.23	0.40	0.32
Asset Turnover	0.50	0.49	0.48	0.57	0.60	0.62
Inventory Turnover	4.10	5.31	7.38	8.87	8.97	10.62
Quick Ratio	1.84	2.17	3.60	4.46	4.04	4.02
Current Ratio	2.36	2.69	3.99	4.83	4.46	4.33
Return on Equity (ROE)	22.31%	-3.15%	22.99%	27.67%	24.93%	36.71%
Return on Assets (ROA)	12.04%	12.14%	13.17%	17.33%	19.32%	19.02%
Return on Capital (ROIC)	15.51%	15.03%	16.22%	21.15%	23.51%	23.29%
Return on Capital Employed (ROCE)	22.30%	23.20%	22.50%	28.40%	34.50%	30.90%
Earnings Yield	3.30%	-0.52%	3.45%	4.48%	4.20%	4.41%
FCF Yield	3.00%	-0.76%	3.18%	5.29%	4.31%	4.87%
Buyback Yield / Dilution	-0.11%	1.00%	-0.54%	0.31%	1.33%	-1.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.